(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Low Testosterone
This study will evaluate an investigational medication for low testosterone. You may qualify if you have low testosterone and are otherwise in good health. Participants will receive study related medical evaluations and study medication at no cost.
The research site is in Oklahoma City, Okla.
More information
Please see http://www.centerwatch.com/patient/studies/cat646.html.
-----
Shingles
This study will evaluate a single-dose extended-release investigational drug and an asymmetric divided dose of that study drug compared to placebo in reducing daily pain due to post-herpetic neuralgia. Volunteers at least 18 who have had pain for at least three months after the healing of herpes zoster skin rash may qualify. Participants may not be pregnant or breastfeeding, cannot have severe pain from causes other than post-herpetic neuralgia, or have a compromised immune system. Additional criteria apply.
The research site is in Wheat Ridge, Colo.
More information
Please see http://www.centerwatch.com/patient/studies/cat225.html.
-----
Erectile Dysfunction
Men with high cholesterol are at much higher-than-average risk of erectile dysfunction (ED). If you are a man aged 18-64, are impotent, and have high cholesterol, you may qualify to help study an investigational use of an approved medication.
The research site is in Phoenix, Ariz.
More information
Please see http://www.centerwatch.com/patient/studies/cat371.html.
-----
Copyright 2006 Thomson CenterWatch. All rights reserved.
